2010Unpublished venueRequires access

Dasatinib, a Kinase Inhibitor to Treat Chronic Myelogenous Leukemia

Jagabandhu Das, Joel C. Barrish

Open publisher page 1 citations

Abstract

This chapter contains sections titled: Introduction Discussion Clinical Findings and Summary References

About this research paper

What this paper is about

This chapter contains sections titled: Introduction Discussion Clinical Findings and Summary References

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Introduction Discussion Clinical Findings and Summary References

Key concepts: Dasatinib, Chronic myelogenous leukemia, Medicine, Tyrosine-kinase inhibitor, Internal medicine, Pharmacology, Cancer research, Leukemia

Related papers

Back to paper searchBrowse research topicsOriginal source
Dasatinib, a Kinase Inhibitor to Treat Chronic Myelogenous Leukemia — Research Paper | ScholarLens